As Oracle slashes jobs, some workers say they were helping develop the AI that displaced them.

AI coding startup Cursor is nearing new funding in which the four-year-old company would raise at least $2 billion in fresh capital, according to four sources familiar with the matter. Returning ...

Elon Musk's AI company xAI plans to allow Cursor to use some of its compute power for training. Cursor will train its AI model Composer 2.5 using tens of thousands of xAI GPUs, sources said. The ...

At Cloud Next this week in Las Vegas, Google made its case this week that it has all the pieces — literally the entire “stack” of technologies from chips to models to data management platforms — ...

Use the following fixes if your mouse cursor won’t move to the second monitor on your Windows 11/10 computer. Check your monitor alignment Disconnect and reconnect your displays Set your Displays to ...

The oracle bone below was discovered in China over 100 years ago. At first, nobody knew what they were. Later, historians realised the words inscribed on them were questions and they were able to work ...

An open-world Mario Kart, a new way to play and chat with friends, and even an exclusive FromSoftware title are all coming to Switch 2 There has never been a better time to pick up some well regarded, ...

The About Us page of your website is an essential source of information for anyone who wants to know more about your business. It is where you showcase your history, the unique value of your work, ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Brian Beers is a digital editor, writer, Emmy-nominated producer, and content expert with 15+ years of experience writing about corporate finance & accounting, fundamental analysis, and investing.

Spurred by the discoveries of human pluripotent stem cell culture by James Thomson in the 1990s and the induction of pluripotency from adult cells by Shinya Yamanaka in the 2000s, therapeutics derived ...